Clinical trial
mRNA Expression as a Biomarker of Xolair (Omalizumab) Response
NCT01584687 is registered in ClinicalTrials.gov with Instituto de Investigação em Imunologia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- mRNA Expression as a Biomarker of Xolair (Omalizumab) Response
- Lead sponsor
- Instituto de Investigação em Imunologia
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2012
- Completion date
- December 31, 2012
- Enrollment
- 6 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.